Indivior | New Data from the RECOVER™ Study Reveal Two-Year Outcomes in People with Opioid Use Disorder Following Transition from Pivotal Phase 3 Clinical Trials to a Real-World Setting

The ongoing RECOVER™ study is assessing real-world, patient-centered outcomes including self-reported sustained illicit opioid-free weeks and life changes, such as improved health, employment status and connection to community following treatment with SUBLOCADE® – Indivior PLC (LON: INDV) announces new data from the two-year analysis of the 24-month real-world observational study, RECOVER™ (Remission from Chronic Opioid Use—Studying Environmental and SocioEconomic Factors on Recovery). Slough, UK and Richmond, VA, June 24, 2020 Read full report here.

The release as fetched from its publisher. indivior.com ↗